In TV ads, the pharmaceutical industry claims congressional plans to allow the federal government to negotiate drug prices in Medicare would deny beneficiaries’ access to medicines their doctors prescribe. Experts say that’s unlikely, and an inaccurate portrayal of recent legislation.
PhRMA Ad Misleads on Medicare Drug Negotiation Legislation
